We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+6.25%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.4B
AUM Growth
+$904M
Cap. Flow
+$84.9M
Cap. Flow %
0.49%
Top 10 Hldgs %
29.78%
Holding
722
New
36
Increased
329
Reduced
218
Closed
40

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$66.4M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.7M
3
AMZN icon
Amazon
AMZN
+$56.5M
4
AMD icon
Advanced Micro Devices
AMD
+$37.5M
5
CRM icon
Salesforce
CRM
+$35.5M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$122M
2
TMO icon
Thermo Fisher Scientific
TMO
+$60.8M
3
AMAT icon
Applied Materials
AMAT
+$43.7M
4
NU icon
Nu Holdings
NU
+$35.9M
5
INCY icon
Incyte
INCY
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 31.8%
2 Healthcare 28.54%
3 Financials 9.44%
4 Consumer Discretionary 7.84%
5 Industrials 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALL icon
201
Allstate
ALL
$67.3B
$17.4M 0.1%
91,879
-90,964
-50% -$16.2M
ADI icon
202
Analog Devices
ADI
$181B
$17.2M 0.1%
74,870
+17,516
+31% +$3.95M
VRDN icon
203
Viridian Therapeutics
VRDN
$2.18B
$17.1M 0.1%
749,804
– –
HST icon
204
Host Hotels & Resorts
HST
$17.1B
$16.9M 0.1%
959,724
-557,439
-37% -$9.68M
HASI icon
205
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.91B
$16.9M 0.1%
488,934
+82,320
+20% +$2.65M
IEX icon
206
IDEX
IEX
$16.6B
$16.7M 0.1%
77,856
+9,330
+14% +$1.88M
LOW icon
207
Lowe's Companies
LOW
$119B
$16.5M 0.09%
54,503
-58,837
-52% -$14.2M
DAR icon
208
Darling Ingredients
DAR
$9.62B
$16.3M 0.09%
439,697
-62,712
-12% -$2.36M
VZ icon
209
Verizon
VZ
$198B
$16.3M 0.09%
362,700
+13,951
+4% +$582K
ANET icon
210
Arista Networks
ANET
$215B
$15.9M 0.09%
166,040
+12,652
+8% +$1.1M
AMRC icon
211
Ameresco
AMRC
$1.12B
$15.9M 0.09%
418,580
+50,521
+14% +$1.56M
DFS
212
DELISTED
Discover Financial Services
DFS
$15.7M 0.09%
112,055
-12,502
-10% -$1.68M
GWRE icon
213
Guidewire Software
GWRE
$12.4B
$15.5M 0.09%
84,527
-103,498
-55% -$15.7M
DXCM icon
214
DexCom
DXCM
$28.3B
$15.4M 0.09%
230,451
+114,702
+99% +$9.42M
THC icon
215
Tenet Healthcare
THC
$21B
$14.9M 0.09%
+89,510
New +$13.5M
RNAM
216
DELISTED
Avidity Biosciences
RNAM
$14.9M 0.09%
+323,396
New +$14M
FWONK icon
217
Liberty Media Series C
FWONK
$24.6B
$14.4M 0.08%
186,080
+170,909
+1,127% +$13.2M
RGA icon
218
Reinsurance Group of America
RGA
$15.7B
$14.2M 0.08%
65,329
+41,474
+174% +$8.82M
EXEL icon
219
Exelixis
EXEL
$14B
$14.2M 0.08%
548,119
-159,516
-23% -$3.96M
ULTA icon
220
Ulta Beauty
ULTA
$20.7B
$14.2M 0.08%
36,469
+11,331
+45% +$4.25M
TXN icon
221
Texas Instruments
TXN
$255B
$14.1M 0.08%
68,095
+2,983
+5% +$599K
DYN icon
222
Dyne Therapeutics
DYN
$4.24B
$14M 0.08%
390,956
-142,317
-27% -$5.66M
MSCI icon
223
MSCI
MSCI
$41.5B
$13.9M 0.08%
23,879
+16,756
+235% +$9.09M
WTRG icon
224
Essential Utilities
WTRG
$11.2B
$13.8M 0.08%
357,445
+28,295
+9% +$1.11M
MFC icon
225
Manulife Financial
MFC
$73.2B
$13.8M 0.08%
465,509
+440,899
+1,792% +$11.8M
7 8
9
10 11

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2024 Portfolio in Review

As of Q3 2024, Candriam SCA held 722 positions worth $17.4B, up 5.5% from $16.5B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Candriam SCA's Q3 2024 filing shows 36 new, 329 increased, 218 reduced and 40 closed positions. Its largest new stake was Avidity Biosciences: 323,396 shares worth $14.9M. The largest sale was Lam Research, an estimated $122M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2024 buy was Avidity Biosciences: 323,396 shares worth $14.9M.
  • Candriam SCA added most to Amgen in Q3 2024, an estimated $66.4M increase.
  • Candriam SCA's biggest Q3 2024 reduction was Thermo Fisher Scientific, cutting an estimated $60.8M.
  • Candriam SCA fully exited Lam Research in Q3 2024, selling an estimated $122M.
  • Candriam SCA's ten largest holdings make up 30% of its $17.4B portfolio in Q3 2024.
  • Candriam SCA opened 36 new positions and closed 40 in Q3 2024.
  • Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $17.4B.

Based on Candriam SCA's 13F filing for Q3 2024, filed 13 Nov 2024.